ジーエヌアイグループの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/06/30 | 2,091 | 2,116 | 2,087 | 2,098 | -8 | -0.4% | 261,600 |
2021/06/29 | 2,129 | 2,157 | 2,092 | 2,106 | -7 | -0.3% | 566,800 |
2021/06/28 | 2,097 | 2,124 | 2,083 | 2,113 | +29 | +1.4% | 344,300 |
2021/06/25 | 2,075 | 2,103 | 2,039 | 2,084 | +18 | +0.9% | 340,100 |
2021/06/24 | 2,087 | 2,126 | 2,058 | 2,066 | -34 | -1.6% | 384,200 |
2021/06/23 | 2,120 | 2,129 | 2,079 | 2,100 | -3 | -0.1% | 304,500 |
2021/06/22 | 2,092 | 2,123 | 2,067 | 2,103 | +59 | +2.9% | 468,600 |
2021/06/21 | 2,065 | 2,087 | 2,020 | 2,044 | -81 | -3.8% | 740,800 |
2021/06/18 | 2,186 | 2,213 | 2,112 | 2,125 | -31 | -1.4% | 717,700 |
2021/06/17 | 2,130 | 2,187 | 2,122 | 2,156 | +9 | +0.4% | 571,600 |
2021/06/16 | 2,158 | 2,176 | 2,118 | 2,147 | -25 | -1.2% | 658,700 |
2021/06/15 | 2,204 | 2,233 | 2,163 | 2,172 | -25 | -1.1% | 618,200 |
2021/06/14 | 2,245 | 2,245 | 2,160 | 2,197 | -37 | -1.7% | 698,500 |
2021/06/11 | 2,325 | 2,330 | 2,226 | 2,234 | -54 | -2.4% | 1,020,600 |
2021/06/10 | 2,277 | 2,308 | 2,234 | 2,288 | -9 | -0.4% | 964,200 |
2021/06/09 | 2,206 | 2,310 | 2,190 | 2,297 | +84 | +3.8% | 1,198,400 |
2021/06/08 | 2,278 | 2,317 | 2,196 | 2,213 | -33 | -1.5% | 1,354,700 |
2021/06/07 | 2,185 | 2,250 | 2,175 | 2,246 | +76 | +3.5% | 730,300 |
2021/06/04 | 2,133 | 2,196 | 2,128 | 2,170 | +30 | +1.4% | 747,300 |
2021/06/03 | 2,094 | 2,150 | 2,076 | 2,140 | +50 | +2.4% | 829,500 |
2021/06/02 | 2,121 | 2,147 | 2,077 | 2,090 | -31 | -1.5% | 719,700 |
2021/06/01 | 2,113 | 2,130 | 2,073 | 2,121 | -3 | -0.1% | 595,400 |
2021/05/31 | 2,071 | 2,133 | 2,049 | 2,124 | +61 | +3% | 795,300 |
2021/05/28 | 2,024 | 2,070 | 2,015 | 2,063 | +56 | +2.8% | 755,400 |
2021/05/27 | 2,000 | 2,021 | 1,972 | 2,007 | +3 | +0.1% | 779,100 |
2021/05/26 | 1,976 | 2,018 | 1,955 | 2,004 | +18 | +0.9% | 692,500 |
2021/05/25 | 1,957 | 2,006 | 1,941 | 1,986 | +29 | +1.5% | 880,000 |
2021/05/24 | 2,004 | 2,016 | 1,937 | 1,957 | -49 | -2.4% | 1,063,700 |
2021/05/21 | 2,009 | 2,042 | 1,957 | 2,006 | +13 | +0.7% | 2,189,700 |
2021/05/20 | 2,195 | 2,215 | 1,988 | 1,993 | -337 | -14.5% | 7,473,900 |
2021/05/19 | 2,153 | 2,334 | 2,130 | 2,330 | +181 | +8.4% | 4,641,600 |
2021/05/18 | 1,958 | 2,178 | 1,950 | 2,149 | +325 | +17.8% | 7,168,600 |
2021/05/17 | 1,915 | 1,930 | 1,811 | 1,824 | -111 | -5.7% | 1,004,300 |
2021/05/14 | 1,854 | 2,021 | 1,831 | 1,935 | +94 | +5.1% | 1,313,600 |
2021/05/13 | 1,846 | 1,891 | 1,793 | 1,841 | -23 | -1.2% | 971,100 |
2021/05/12 | 2,003 | 2,022 | 1,812 | 1,864 | -144 | -7.2% | 2,109,900 |
2021/05/11 | 1,985 | 2,024 | 1,983 | 2,008 | +8 | +0.4% | 608,400 |
2021/05/10 | 2,033 | 2,037 | 2,000 | 2,000 | ±0 | ±0% | 236,000 |
2021/05/07 | 1,986 | 2,044 | 1,960 | 2,000 | ±0 | ±0% | 492,800 |
2021/05/06 | 2,043 | 2,052 | 1,995 | 2,000 | -41 | -2% | 486,500 |
2021/04/30 | 2,026 | 2,041 | 2,006 | 2,041 | +11 | +0.5% | 262,600 |
2021/04/28 | 2,087 | 2,096 | 2,020 | 2,030 | -57 | -2.7% | 475,500 |
2021/04/27 | 2,060 | 2,121 | 2,050 | 2,087 | +45 | +2.2% | 611,500 |
2021/04/26 | 2,020 | 2,044 | 1,991 | 2,042 | +19 | +0.9% | 383,600 |
2021/04/23 | 2,026 | 2,089 | 2,017 | 2,023 | -1 | ±0% | 627,900 |
2021/04/22 | 2,012 | 2,038 | 2,003 | 2,024 | +40 | +2% | 421,700 |
2021/04/21 | 1,990 | 2,010 | 1,965 | 1,984 | -28 | -1.4% | 729,100 |
2021/04/20 | 1,998 | 2,026 | 1,986 | 2,012 | +7 | +0.3% | 400,000 |
2021/04/19 | 2,050 | 2,054 | 1,999 | 2,005 | -45 | -2.2% | 470,900 |
2021/04/16 | 2,030 | 2,077 | 2,030 | 2,050 | +20 | +1% | 457,100 |
801~
850
件表示中 / 3553件
類似銘柄と比較する
現在ご覧いただいている「ジーエヌアイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ジーエヌアイ | 285,000円 | +52.1% | +23.3% | 0.00% | 20.21倍 | 3.87倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
科研薬 | 386,000円 | +22.8% | +113.0% | 4.92% | 10.29倍 | 1.02倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
東和薬品 | 316,000円 | +14.7% | -21.6% | 1.90% | 12.35倍 | 1.00倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
持田薬 | 348,000円 | +3.0% | +27.5% | 2.30% | 22.03倍 | 0.96倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ゼリア新薬 | 232,400円 | +9.6% | +17.5% | 1.98% | 13.13倍 | 1.29倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム